(Q34813567)

4 August 2017

title

Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

4 August 2017

main subject

0 references

author

Suryasarathi Dasgupta

series ordinal

1

object named as

Suryasarathi Dasgupta

1 reference

4 August 2017

Dennis L Kasper

2

1 reference

4 August 2017

publication date

1 October 2013

1 reference

Inflammatory Bowel Diseases

4 August 2017

published in

1 reference

4 August 2017

volume

19

1 reference

4 August 2017

issue

11

1 reference

4 August 2017

page(s)

2478-2489

1 reference

Host-gut microbiota metabolic interactions

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Fecal microflora of Greek healthy neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Food and the gut microbiota in inflammatory bowel diseases: a critical connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

The role of the gut microbiota in nutrition and health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Intestinal microflora and immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

A microbial symbiosis factor prevents intestinal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Orientations of theBacteroides fragilisCapsular Polysaccharide Biosynthesis Locus Promoters during Symbiosis and Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Balancing acts: the role of TGF-β in the mucosal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

CD8α⁺β⁻ and CD8α⁺β⁺ plasmacytoid dendritic cells induce Foxp3⁺ regulatory T cells and prevent the induction of airway hyper-reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Plasmacytoid dendritic cells mediate oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Environmental influences on T regulatory cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

IL-10 and its related cytokines for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

IL-10 gene therapy prevents TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Experimental Inflammatory Bowel Disease: Insights into the Host-Microbiota Dialog

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Bacterial flagellin is a dominant antigen in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Role of commensal gut bacteria in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Role of the gut microbiota in age-related chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Contributions of the microbial hydrogen economy to colonic homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

RETRACTED: Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Gut microbiota composition correlates with diet and health in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Detecting and treating Clostridium difficile infections in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Intestinal superinfections in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Enteropathogenic viruses: triggers for exacerbation in IBD? A prospective cohort study using real-time quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Fecal microbiota transplantation and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Fecal microbiota transplantation in relapsing Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Immunomodulation by commensal and probiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Spores from two distinct colony types of the strain Bacillus subtilis PB6 substantiate anti-inflammatory probiotic effects in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Differential targeting of the E-Cadherin/β-Catenin complex by gram-positive probiotic lactobacilli improves epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Lactobacillus paracaseiReduces Intestinal Inflammation in Adoptive Transfer Mouse Model of Experimental Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Nutrigenomics and nutrigenetics in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Galactooligosaccharides: novel components of designer foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Amelioration of dextran sodium sulfate-induced colitis in mice by Rhodobacter sphaeroides extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Polysaccharide processing and presentation by the MHCII pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Gut immune maturation depends on colonization with a host-specific microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Buyer beware: therapeutic claims of probiotics marketed to Crohn's disease patients via the internet lack supporting data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Intestinal inflammation targets cancer-inducing activity of the microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Host remodeling of the gut microbiome and metabolic changes during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Compartmentalized control of skin immunity by resident commensals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318297D884

10.1097/MIB.0B013E318297D884

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference